Weihai Baihe Biology Technological Co (603102) Fair Value & Analysis
Consumer Defensive · CN · Market cap 2.4B CNY
Fair value as of: Aug 10, 2026
From 24 valuation models · updated today
Share price +22.6% over the past month.
A solid business, currently priced close to our fair value.
What matters now
- The price sits close to our fair value, market and models broadly agree here, little valuation tension.
- Our model range runs from ¥31.61 (bear) to ¥52.68 (bull), base ¥42.14. The closer the price sits to the lower half, the larger the margin of safety.
- Quality 68/100 (solid quality) with high evidence: the data supports the verdict.
Price vs Fair Value (5 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Aug 10, 2026.
How to read this chart
54‑month range ¥27.67 – ¥68.72 · fair‑value band ¥31.61 – ¥52.68 · the ¥39.75 price screens below the ¥42.14 fair value. Dashed = 300-day average. As of Aug 10, 2026.
Analysis
Weihai Baihe Biology Technological Co (603102) currently trades at ¥39.75, while our model-based Fair Value estimate is ¥42.14, implying the stock looks roughly 6.0% fairly valued today. The Quality Score stands at 68/100 (solid quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Weihai Baihe Biology Technological Co generated revenue of 956M CNY at a net margin of 12.8%. Revenue grew 21.7% year over year. It earns a return on equity of 7.8%. The stock trades on a trailing P/E of 17.9. Fundamentals as of Aug 10, 2026
Our scenario range runs from ¥31.61 (bear case) to ¥52.68 (bull case); at ¥39.75, the current price sits within that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 23% below its 52-week high and 16% above its 52-week low, currently below its 200-day average. For context, the median of 10 Consumer Defensive peers we cover trades at -3% fair-value upside, at 6%, 603102 screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: DCF Models (¥58.97) versus Asset-Based (¥17.33). Highest evidence: Residual Income (76).
Notify me when 603102 reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Aug 10, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 68 · Market factors (momentum, volatility) 43
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food products in China and internationally.
Full company description
Weihai Baihe Biology Technological Co., Ltd., together with its subsidiary, Weihai Lily Functional Food Technology Research Institute Limited Company, research, develops, manufactures, and sells nutrition and health food products in China and internationally. The company offers health food; nutritious food for feminine glamour, male energy, elderly care, pregnancy, babies, and childcare, as well as nutritional soft candies; special diet products comprising supplementary food and nutritional supplements, nutritional supplements for pregnant women and lactating mothers, and sports nutrition supplements; and official approval services for health food declarations, as well as produces and sells pet food. It provides its products in the form of soft and hard capsules, tablets, powders, oral liquids, drops, and bottled and bagged beverages. The company sells its products under the Biohek, Hongyangshen, Yunyangyan, Forzal, Zulixing, and Nengbeijian brands. It also exports its products to approximately 70 countries, including Europe and the United States. Weihai Baihe Biology Technological Co., Ltd. was founded in 1996 and is headquartered in Rongcheng, China.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Weihai Baihe Biology Technological Co reported revenue of ¥911M in FY2025 versus ¥662M in FY2021, a compound +8.3%/yr. Reported net income was ¥128M in FY2025, compounding −3.5%/yr from FY2021.
Watch 603102: get an alert when its fair value changes →
Peer Group
Packaged Foods · 649 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Packaged Foods median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Packaged Foods stocks, each showing price versus our Fair Value estimate (as of Aug 10, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Nestlé India Limited NESTLEIND | ₹1,427 | ₹362.37 | -75% |
| Britannia Industries Limited BRITANNIA | ₹5,413 | ₹1,870 | -65% |
| Tata Consumer Products Limited TATACONSUM | ₹1,089 | ₹327.27 | -70% |
| PT Indofood CBP Sukses Makmur Tbk ICBP | 6,650 IDR | 15,757 IDR | +137% |
| Samyang Foods Co 003230 | 1,139,000 KRW | 1,010,543 KRW | -11% |
| Patanjali Foods Limited PATANJALI | ₹413.80 | ₹157.04 | -62% |
| Vietnam Dairy Products Joint Stock Company VNM | 58,500 VND | 68,259 VND | +17% |
| PT Mayora Indah Tbk, MYOR | 1,750 IDR | 2,699 IDR | +54% |
| PT Cisarua Mountain Dairy Tbk CMRY | 4,490 IDR | 4,355 IDR | -3% |
| Nongshim Co 004370 | 348,500 KRW | 530,619 KRW | +52% |
Compare Weihai Baihe Biology Technological Co with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Consumer Defensive stocks →
Frequently asked questions
Is Weihai Baihe Biology Technological Co (603102) overvalued or undervalued?
What is the fair value of 603102?
What is the quality score of 603102?
What is the revenue of Weihai Baihe Biology Technological Co (603102)?
What is the net profit margin of 603102?
Does Weihai Baihe Biology Technological Co pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Weihai Baihe Biology Technological Co and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.